GRIK1 Genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink
Open Access
- 30 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 17 (10) , 1549-1556
Abstract
We ( Kranzler et al., 2014 ) reported that topiramate 200 mg/day reduced heavy drinking days and increased abstinent days in 138 heavy drinkers whosKeywords
This publication has 38 references indexed in Scilit:
- Glutamatergic targets for new alcohol medicationsPsychopharmacology, 2013
- Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesityTherapeutic Advances in Neurological Disorders, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- The predictive validity of the Drinking-Related Cognitions Scale in alcohol-dependent patients under abstinence-oriented treatmentSubstance Abuse Treatment, Prevention, and Policy, 2012
- Measurement of admixture proportions and description of admixture structure in different U.S. populationsHuman Mutation, 2009
- Association of Markers in the 3′ Region of the GluR5 Kainate Receptor Subunit Gene to Alcohol DependenceAlcohol, Clinical and Experimental Research, 2009
- Do Good Things Come to Those Who Drink? A Longitudinal Investigation of Drinking Expectancies and Hazardous Alcohol Use in Female College AthletesJournal of Adolescent Health, 2006
- The Obsessive Compulsive Drinking Scale: A Self‐Rated Instrument for the Quantification of Thoughts about Alcohol and Drinking BehaviorAlcohol, Clinical and Experimental Research, 1995
- Comprehensive effects of alcohol: Development and psychometric assessment of a new expectancy questionnaire.Psychological Assessment, 1993
- Drinking habits and expectancies about alcohol's effects for self versus others.Journal of Consulting and Clinical Psychology, 1983